High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B
Name:
101115_Chappuis_VL-45yo-high-m ...
Size:
236.9Kb
Format:
PDF
Description:
Main article
Affiliation
Médecins Sans Frontières, Geneva, Switzerland; Médecins Sans Frontières, Amsterdam, The NetherlandsIssue Date
2010-11-15
Metadata
Show full item recordAbstract
Visceral leishmaniasis (VL; kala azar), a fatal disease if left untreated, is one of the most neglected tropical diseases....PubMed ID
21078947Additional Links
http://aac.asm.org/cgi/content/abstract/AAC.01298-10v1Type
ArticleLanguage
enISSN
1098-6596ae974a485f413a2113503eed53cd6c53
10.1128/AAC.01298-10
Scopus Count
Collections
Related articles
- Visceral leishmaniasis and Coombs' positive hemolytic anemia: a rare association in an infant treated with liposomal amphotericin B.
- Authors: Dilber E, Erduran E, Işik Y
- Issue date: 2002 Oct-Dec
- [Liposomal amphotericin B as treatment for visceral leishmaniasis in Europe, 2009].
- Authors: Rosenthal E, Delaunay P, Jeandel PY, Haas H, Pomares-Estran C, Marty P
- Issue date: 2009 Oct
- Liposomal amphotericin B for the treatment of visceral leishmaniasis.
- Authors: Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L, Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J
- Issue date: 2006 Oct 1
- Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients.
- Authors: Vigna E, De Vivo A, Gentile M, Morelli R, Lucia E, Mazzone C, Recchia AG, Vianelli N, Morabito F
- Issue date: 2010 Oct
- Drug regimens for visceral leishmaniasis in Mediterranean countries.
- Authors: Gradoni L, Soteriadou K, Louzir H, Dakkak A, Toz SO, Jaffe C, Dedet JP, Campino L, Cañavate C, Dujardin JC
- Issue date: 2008 Oct